StockData
Abbott Laboratories logo

Abbott Laboratories (ABT) stock

ABTNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 14/3034% above fair value
$104.71−2.74 (-2.55%)

Close on Nov 17, 2026Market cap $181.19BP/E 33.7Yield 2.29%

Abbott Laboratories price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Abbott Laboratories's price to book ratio was 3.7× on Nov 11, 2026, against 4.4× a year earlier. Over the last 5 years it ranged from 2.9× to 7.3×, with a median of 4.9×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20263.7×−0.6
2025Dec 31, 20254.3×−0.7
2024Dec 31, 20245.0×−0.2
2023Dec 29, 20235.1×−0.3
2022Dec 30, 20225.5×−1.9
2021Dec 31, 20217.3×+1.1
2020Dec 31, 20206.2×+1.4
2019Dec 31, 20194.9×+0.7
2018Dec 31, 20184.2×+1.2
2017Dec 29, 20173.0×+0.3
2016Dec 30, 20162.7×−0.5
2015Dec 31, 20153.2×+0.2
2014Dec 31, 20143.0×+0.5
2013Dec 31, 20132.6×−1.3
2012Dec 31, 20123.8×+0.3
2011Dec 30, 20113.6×+0.1
2010Dec 31, 20103.5×−0.5
2009Dec 31, 20093.9×–

More Abbott Laboratories figures

See a number that looks wrong?